Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of TD SYNNEX CORP from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
TD SYNNEX CORP quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q4 2014 to Q4 2023.
  • TD SYNNEX CORP Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Nov 2023 was $1.03B, a 97.7% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

TD SYNNEX CORP Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.03B +$511M +97.7% 30 Nov 2023 10-K 26 Jan 2024
Q3 2023 $1.25B +$900M +256% 31 Aug 2023 10-Q 03 Oct 2023
Q2 2023 $852M +$330M +63.3% 31 May 2023 10-Q 06 Jul 2023
Q1 2023 $539M +$28.9M +5.66% 28 Feb 2023 10-Q 05 Apr 2023
Q4 2022 $523M -$472M -47.4% 30 Nov 2022 10-K 26 Jan 2024
Q3 2022 $351M -$3.7B -91.3% 31 Aug 2022 10-Q 03 Oct 2023
Q2 2022 $522M -$1.14B -68.5% 31 May 2022 10-Q 06 Jul 2023
Q1 2022 $510M -$934M -64.7% 28 Feb 2022 10-Q 05 Apr 2023
Q4 2021 $995M -$574M -36.6% 30 Nov 2021 10-Q 03 Oct 2023
Q3 2021 $4.05B +$2.59B +178% 31 Aug 2021 10-Q 04 Oct 2022
Q2 2021 $1.66B +$540M +48.4% 31 May 2021 10-Q 07 Jul 2022
Q1 2021 $1.44B +$1.14B +379% 28 Feb 2021 10-Q 08 Apr 2021
Q4 2020 $1.57B +$1.42B +963% 30 Nov 2020 10-Q 04 Oct 2022
Q3 2020 $1.46B +$1.19B +445% 31 Aug 2020 10-Q 09 Oct 2020
Q2 2020 $1.12B +$841M +304% 31 May 2020 10-Q 09 Jul 2020
Q1 2020 $301M +$51.7M +20.7% 29 Feb 2020 10-Q 07 Apr 2020
Q4 2019 $148M -$314M -68% 30 Nov 2019 8-K 01 Sep 2021
Q3 2019 $267M +$56.3M +26.7% 31 Aug 2019 10-Q 09 Oct 2020
Q2 2019 $277M -$84M -23.3% 31 May 2019 10-Q 09 Jul 2020
Q1 2019 $250M -$129M -34% 28 Feb 2019 10-Q 07 Apr 2020
Q4 2018 $462M -$94.7M -17% 30 Nov 2018 10-K 28 Jan 2021
Q3 2018 $211M -$36.2M -14.6% 31 Aug 2018 10-Q 04 Oct 2019
Q2 2018 $361M +$50.6M +16.3% 31 May 2018 10-Q 03 Jul 2019
Q1 2018 $378M +$165M +77% 28 Feb 2018 10-Q 09 Apr 2019
Q4 2017 $557M +$170M +43.8% 30 Nov 2017 10-K 28 Jan 2021
Q3 2017 $247M +$20.6M +9.09% 31 Aug 2017 10-Q 09 Oct 2018
Q2 2017 $310M -$281M -47.6% 31 May 2017 10-Q 06 Jul 2018
Q1 2017 $214M 28 Feb 2017 10-Q 06 Apr 2018
Q4 2016 $387M -$37.5M -8.82% 30 Nov 2016 10-K 29 Jan 2020
Q3 2016 $227M 31 Aug 2016 10-Q 03 Oct 2017
Q2 2016 $591M 31 May 2016 10-Q 05 Jul 2017
Q4 2015 $425M +$210M +98% 30 Nov 2015 10-K 28 Jan 2019
Q4 2014 $214M 30 Nov 2014 10-K 29 Jan 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.